Collaboration aims to reduce neurodegeneration in MS

[MSUK]

University of Edinburgh and Genzyme collaboration aims to reduce neurodegeneration in MS

University of Edinburgh scientists are set to work with leading biotechnology company Genzyme, a Sanofi company, to carry out drug discovery research that could reduce neuron damage in the brain.

The collaboration - facilitated by Edinburgh BioQuarter's Business Development team - will focus on identifying therapeutic candidates capable of promoting remyelination and reducing neurodegeneration, mostly in relation to Multiple Sclerosis (MS)............ Read More - http://www.ms-uk.org/myelin